A cannabis-derived drug developed by Germany's Vertanical has shown efficacy in phase 3 as a treatment for chronic pain, offering the prospect of an alternative to opioid drugs that carry the risk of ...

Sanofi chief executive Belén Garijo. Shortly after terminating one late-stage R&D programme, Sanofi has confirmed two others are being abandoned as part of a revamp under new chief executive Belén ...

Ireland is attracting major investment from the largest pharma companies in the world. Ben Hargreaves finds out how the country has become one of the most significant locations in Europe for ...

Henry Gosebruch, pictured here during his time at Neumora, is replacing Paul Stoffels as CEO of Galapagos. Just a few months after announcing a plan to separate its drug and cell therapy businesses ...

KalVista Pharma has finally received FDA approval for its oral kallikrein inhibitor sebetralstat, becoming the first treatment in the US that can provide oral, on-demand treatment of hereditary ...

Two TROP2-targeting antibody-drug conjugates, Datroway and Trodelvy, have new data suggesting they could become options for previously untreated patients with triple-negative breast cancer (TNBC).

Cidara Therapeutics is celebrating a major injection of funding from the US government that will be used to support the development of its experimental preventive therapy for influenza. The sizeable ...

Reports are emerging that a multibillion-dollar partnership between AbbVie and Alphabet-backed biotech Calico has come to an end after more than a decade. The divorce – first report by Stat – comes ...

Regeneron has agreed a $109 million deal to acquire Decibel Therapeutics and its early-stage gene therapy for a form of congenital deafness, several years after forming a partnership to tackle hearing ...

Four Democratic senators are investigating whether the family of HHS Secretary Robert F Kennedy Jr is profiting from what they assert are "bogus" vaccine lawsuits. In particular, they want to know if ...

A woman from the Wirral in the UK has become the first patient in the world to receive an experimental cancer vaccine developed by a consortium of academic organisations and biotech companies. Chris ...

The second batch of Commissioner's national priority vouchers (CNPVs) has been published by the FDA, and includes new GLP-1 agonists for weight-loss from Eli Lilly and Novo Nordisk and drugs for ...